DLX5

Source: Wikipedia, the free encyclopedia.
DLX5
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_005221

NM_010056
NM_198854

RefSeq (protein)

NP_005212

NP_034186
NP_942151

Location (UCSC)Chr 7: 97.02 – 97.02 MbChr 6: 6.88 – 6.88 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Homeobox protein DLX-5 is a protein that in humans is encoded by the distal-less homeobox 5 gene, or DLX5 gene.[5][6] DLX5 is a member of the DLX gene family.

Function

This gene encodes a member of a homeobox transcription factor gene family similar to the Drosophila distal-less (Dll) gene. The encoded protein may play a role in bone development and fracture healing. Current research holds that the homeobox gene family is important in appendage development. DLX5 and DLX6 can be seen to work in conjunction and are both necessary for proper craniofacial, axial, and appendicular skeleton development. Mutations in this gene, which is located in a tail-to-tail configuration with DLX6 on the long arm of chromosome 7, may be associated with split-hand/split-foot malformation.[6]

DLX5 also acts as the early BMP-responsive transcriptional activator needed for osteoblast differentiation by stimulating the up-regulation of a variety of promoters (ALPL promoter, SP7 promoter, MYC promoter).[7]

Clinical significance

Mutations in the DLX5 gene have been shown to be involved in the

ectodermal
and craniofacial findings, and orofacial clefting.

In mice, the targeted disruption of DLX1, DLX2, DLX1/2, or DLX5 orthologs yields craniofacial, bone, and vestibular defects. If DLX5 is disrupted in conjunction with DLX6, bone, inner ear, and severe craniofacial defects are prevalent. Research utilizing Dlx5/6-nulls suggests that these genes have both unique and redundant functions.[9]

Role in development

DLX5 begins to express DLX5 protein in the facial and

frontonasal ectoderm at around day 8.5-9. By day 12.5, DLX5 protein begins to be expressed in the brain, bones, and all remaining skeletal structures. Expression in the brain and skeleton begins to decrease by day 17.[7]

Interactions

DLX5 has been shown to

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000105880 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029755 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. PMID 7907794
    .
  6. ^ a b "Entrez Gene: DLX5 distal-less homeobox 5".
  7. ^ a b "Homeobox protein DLX-5".
  8. S2CID 25692622
    .
  9. ^ .
  10. ^ .

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This page is based on the copyrighted Wikipedia article: DLX5. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy